右侧感染性心内膜炎的外科治疗结局分析
该研究回顾了2002年至2015年间134例因右侧感染性心内膜炎接受手术的成人患者,按易感条件分组分析住院结局、时间相关死亡和再手术。结果显示总体结局因患者状况而非易感条件而异,注射吸毒者再手术风险更高,三尖瓣置换结局劣于修复/重建,应尽可能避免置换。
要点
- 注射吸毒者早期生存最佳但再手术风险更高(P = .03)。
- 三尖瓣置换术后生存劣于修复/重建,应尽可能避免置换。
- 估计肾小球滤过率是死亡的最强危险因素,而非易感条件。
核心结论
- 右侧感染性心内膜炎术后总体结局多变,受患者状况影响而非易感条件。
- 注射吸毒与感染性心内膜炎再手术风险升高相关。
- 更早的手术可能允许更多瓣膜修复并改善结局。
- 应尽可能避免三尖瓣置换。
研究设计与样本
- 回顾性队列研究,纳入2002年1月至2015年1月间134例因右侧感染性心内膜炎接受手术的成人患者。
- 按易感条件分组,分析住院结局、时间相关死亡和因感染性心内膜炎再手术。
主要发现
- 127例(95%)为三尖瓣感染性心内膜炎,7例(5%)为肺动脉瓣感染性心内膜炎。
- 66例(49%)为孤立性右侧感染性心内膜炎,68例(51%)为左右侧合并感染性心内膜炎。
- 易感条件包括注射吸毒(30%)、心脏植入装置(26%)、慢性血管通路(19%)和其他/无(25%)。
- 1例自体三尖瓣被切除,76%行修复或重建,23%行置换。
- 注射吸毒者无住院死亡,慢性血管通路患者5年生存率最差(18%)。
临床怎么用
- 对右侧感染性心内膜炎患者应尽早考虑手术,以增加瓣膜修复机会。
- 手术策略应优先选择三尖瓣修复或重建,尽可能避免三尖瓣置换。
- 注射吸毒患者术后需加强随访,警惕再手术风险。
- 评估死亡风险时应重点关注肾功能(估计肾小球滤过率),而非仅依据易感条件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Right-sided infective endocarditis is increasing because of increasing prevalence of predisposing conditions, and the role and outcomes of surgery are unclear. We therefore investigated the surgical outcomes for right-sided infective endocarditis. METHODS: From January 2002 to January 2015, 134 adults underwent surgery for right-sided infective endocarditis. Patients were grouped according to predisposing condition. Hospital outcomes, time-related death, and reoperation for infective endocarditis were analyzed. RESULTS: A total of 127 patients (95%) had tricuspid valve and 7 patients (5%) pulmonary valve infective endocarditis; 66 patients (49%) had isolated right-sided infective endocarditis, and 68 patients (51%) had right- and left-sided infective endocarditis. Predisposing conditions included injection drug use (30%), cardiac implantable devices (26%), chronic vascular access (19%), and other/none (25%). One native tricuspid valve was excised, 76% were repaired or reconstructed, and 23% were replaced. Intensive care unit and postoperative hospital stays were similar among groups. Injection drug users had the best early survival (no hospital mortality), and patients with chronic vascular access had the worst late survival (18% at 5 years). Survival was worst for concomitant mitral valve versus isolated right-sided infective endocarditis or concomitant aortic valve infective endocarditis. Survival after tricuspid valve replacement was worse than after repair/reconstruction. Estimated glomerular filtration rate was the strongest risk factor for death, not predisposing condition. Eleven patients underwent 12 reoperations for infective endocarditis; more reoperations occurred in injection drug users (P = .03). CONCLUSIONS: Overall outcomes after surgery are variable and affected by patient condition, not predisposing condition. Injection drug use carries a higher risk of reoperation for infective endocarditis. Earlier surgery may permit more valve repairs and improve outcomes. Whenever possible, tricuspid valve replacement should be avoided.
引用
- Witten JC, Hussain ST, Shrestha NK, et al. Surgical treatment of right-sided infective endocarditis. J Thorac Cardiovasc Surg. 2018. PMID: 30503743. doi:10.1016/j.jtcvs.2018.07.112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。